​

Humana (HUM) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HUM Stock Forecast

Humana (HUM) stock forecast, based on 39 Wall Street analysts, predicts a 12-month average price target of $248.00, with a high of $248.00 and a low of $248.00. This represents a -6.23% decline from the last price of $264.48.

$200 $260 $320 $380 $440 $500 High: $248 Avg: $248 Low: $248 Last Closed Price: $264.48

HUM Stock Rating

Humana stock's rating consensus is Hold, based on 39 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (35.90%), 25 Hold (64.10%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 39 0 25 14 Strong Sell Sell Hold Buy Strong Buy

HUM Price Target Upside V Benchmarks

TypeNameUpside
StockHumana-6.23%
SectorHealthcare Stocks 35.25%
IndustryHealthcare Plans Stocks9.11%

Price Target Trends

1M3M12M
# Anlaysts--16
Avg Price Target--$328.19
Last Closing Price$264.48$264.48$264.48
Upside/Downside--24.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 252519--26
Mar, 253518--26
Feb, 253617--26
Jan, 253717--27
Dec, 242718--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 04, 2024George HillDeutsche Bank$248.00$287.65-13.78%-6.23%
Oct 22, 2024George HillDeutsche Bank$250.00$260.57-4.06%-5.47%
Oct 10, 2024Andrew MokBarclays$250.00$245.451.85%-5.47%
Oct 08, 2024Ben HendrixRBC Capital$265.00$236.2912.15%0.20%
Oct 07, 2024David WindleyJefferies$253.00$240.035.40%-4.34%
Oct 03, 2024Jessica TassanPiper Sandler$274.00$239.3214.49%3.60%
Oct 02, 2024Kevin FischbeckBank of America Securities$247.00$246.490.21%-6.61%
Sep 27, 2024David WindleyJefferies$419.00$319.5731.11%58.42%
Sep 05, 2024Frank MorganRBC Capital$400.00$364.069.87%51.24%
Aug 01, 2024Michael WiederhornOppenheimer$400.00$361.6110.62%51.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 04, 2024Deutsche BankHoldHoldhold
Nov 06, 2024Bank of America SecuritiesNeutralNeutralupgrade
Oct 22, 2024Deutsche BankHoldHoldhold
Oct 11, 2024OppenheimerOutperformOutperformhold
Oct 10, 2024KeyBancSector Weightinitialise
Oct 10, 2024BarclaysEqual-WeightEqual-Weighthold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Oct 08, 2024BernsteinMarket PerformOutperformupgrade
Oct 07, 2024Zacks Investment ResearchNegativedowngrade
Oct 07, 2024Cowen & Co.BuyHolddowngrade

Financial Forecast

EPS Forecast

$10 $17 $24 $31 $38 $45 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$25.47$22.79$22.20$20.09$10.02----
Avg Forecast$18.66$20.54$25.06$27.17$16.15$16.73$14.11$23.92$38.29
High Forecast$19.53$21.49$26.44$27.47$16.29$17.53$16.80$30.54$41.24
Low Forecast$18.22$20.04$24.16$25.31$15.89$16.19$11.18$18.59$36.48
Surprise %36.50%10.95%-11.41%-26.06%-37.96%----

Revenue Forecast

$70B $85B $100B $115B $130B $145B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$77.16B$83.06B$92.87B$106.37B$117.76B----
Avg Forecast$76.06B$83.07B$92.96B$104.82B$117.02B$119.65B$120.24B$127.73B$134.70B
High Forecast$78.78B$86.04B$96.92B$105.19B$117.38B$125.04B$120.47B$128.10B$142.69B
Low Forecast$74.65B$81.54B$90.40B$104.65B$116.54B$116.84B$120.01B$127.35B$129.81B
Surprise %1.44%-0.01%-0.09%1.49%0.63%----

Net Income Forecast

$1B $2B $3B $4B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.37B$2.93B$2.81B$2.49B$1.21B----
Avg Forecast$2.75B$2.79B$2.95B$2.49B$2.00B$2.10B$1.59B$2.40B$4.76B
High Forecast$3.41B$3.35B$3.55B$2.99B$2.03B$2.18B$2.09B$3.80B$5.13B
Low Forecast$2.09B$2.22B$2.36B$1.99B$1.98B$2.01B$1.39B$2.31B$4.54B
Surprise %22.45%5.24%-4.94%--39.70%----

HUM Forecast FAQ

Is Humana stock a buy?

Humana stock has a consensus rating of Hold, based on 39 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 25 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Humana is a neutral investment for most analysts.

What is Humana's price target?

Humana's price target, set by 39 Wall Street analysts, averages $248 over the next 12 months. The price target range spans from $248 at the low end to $248 at the high end, suggesting a potential -6.23% change from the previous closing price of $264.48.

How does Humana stock forecast compare to its benchmarks?

Humana's stock forecast shows a -6.23% downside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the healthcare plans stocks industry (9.11%).

What is the breakdown of analyst ratings for Humana over the past three months?

  • April 2025: 7.69% Strong Buy, 19.23% Buy, 73.08% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 11.54% Strong Buy, 19.23% Buy, 69.23% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 11.54% Strong Buy, 23.08% Buy, 65.38% Hold, 0% Sell, 0% Strong Sell.

What is Humana’s EPS forecast?

Humana's average annual EPS forecast for its fiscal year ending in December 2025 is $16.73, marking a 66.97% increase from the reported $10.02 in 2024. Estimates for the following years are $14.11 in 2026, $23.92 in 2027, and $38.29 in 2028.

What is Humana’s revenue forecast?

Humana's average annual revenue forecast for its fiscal year ending in December 2025 is $119.65B, reflecting a 1.60% increase from the reported $117.76B in 2024. The forecast for 2026 is $120.24B, followed by $127.73B for 2027, and $134.7B for 2028.

What is Humana’s net income forecast?

Humana's net income forecast for the fiscal year ending in December 2025 stands at $2.1B, representing an 73.85% increase from the reported $1.21B in 2024. Projections indicate $1.59B in 2026, $2.4B in 2027, and $4.76B in 2028.